Women and girls need to feel safe in the sporting world.
Business + Economy – Articles, Analysis, Comment
Displaying 301 - 325 of 5818 articles
Managers can feel isolated as they move up the professional ladder – and it has implications for how well a workplace functions.
Will higher minimum wages put employers off young workers?
One-third of students in an OECD survey said school has not taught them anything useful for a job.
Better financial literacy could help consumers avoid the dread of the January debt reckoning.
The loss of the central role of people in today’s complex global systems is the greatest danger of all. In Kenya and Amdo Tibet, it can be rediscovered.
Businesses will not shoulder extra costs alone.
Less than 4% of young workers now belong to a union.
Farmers are struggling to adapt to climate change and its challenges, but new research has some helpful advice.
Festive advertising is often designed around things that sparkle.
Confusion could be a big threat to accepting autonomous vehicles.
More extreme weather is set to cause more more problems for farmers and supermarkets in getting food to consumers.
The perfect gift probably isn’t what you think it is.
From content moderation to hardware supply chains, exploitation looms large.
If AI can be built to increase consumption, then the opposite is also possible.
Workers are clinging to their roles and there’s little space for entry-level candidates.
Christmas consumerism, with all its festive music and heart-warming advertising, relaxes people’s usual restraint.
Money and morality are a challenging corporate combination.
The Indigenous Sami in the far north of Sweden say intensive industrial projects pose risks to their way of life.
The country can’t keep tinkering with a dysfunctional tax system and expect things to get better.
The erosion of trust in the US as the steward of the liberal international order should be taken seriously.
We don’t just shop with our eyes – touch has a big influence too.
Clogged up Britain
Psychedelic medicine is surging back into favour in 2025, but the very features that make these drugs promising may be the hardest to commercialise.
Sometimes it benefits businesses and governments to play up the ‘duped consumer’ narrative.